In recent years, weight loss medications have become a hot topic, especially as more people look for effective ways to lose weight and improve their health. Among these, GLP-1 agonists injectable medications like Mounjaro and Wegovy have gained attention for their ability to help people lose weight and lower blood sugar levels.
These drugs work by mimicking the action of glucagon-like peptide 1, a hormone that helps regulate both appetite and blood sugar. By reducing hunger and slowing how quickly food leaves the stomach, GLP-1 agonists can lead to significant weight loss and better blood sugar control.
However, it’s important to remember that these medications are not a one-size-fits-all solution. Before starting any weight loss treatment, it’s essential to talk with a healthcare provider who can help determine the best approach for your unique needs, discuss the potential benefits and risks, and monitor your progress to ensure the treatment is both safe and effective.
Why GLP-1 Weight Loss Drugs Are Not a Permanent Solution
A ‘magic injection’? The moment you stop the medication, your lost weight returns with 67% interest.
“I lost 15 kg in just three months.”
I don’t even think about alcohol anymore, and food doesn’t go down.
Social media is now filled with praise for these so-called ‘miracle weight-loss drugs.’ GLP-1 medications like Wegovy, Saxenda, and Mounjaro are undeniably powerful. They produce more dramatic effects than any obesity treatment humanity has ever developed.
But doctors hesitate to ask their patients this one question:
So… will you be taking this injection for the rest of your life?
A study by a research team at the University of Liverpool (Diabetes Obesity & Metabolism, 2022) revealed a shocking conclusion. People who lost 17% of their body weight through medication regained 67% of the lost weight within one year of stopping the drug. When patients stop taking GLP-1 drugs, they often experience significant weight gain, highlighting the challenge of maintaining weight loss after discontinuation.
Someone who went from 100 kg to 83 kg returned to 94 kg almost instantly.
This is not because you lack willpower. The drug temporarily turned off the faucet called ‘appetite,’ but the underlying ‘broken system’ of obesity was left untouched.
How GLP-1 Drugs Like Wegovy and Mounjaro Affect Your Weight Loss
GLP-1 drugs for weight loss work by mimicking hormones in your gut that regulate appetite and blood sugar. These medications are known as glucagon-like peptide 1 (GLP-1) receptor agonists, or ‘like peptide 1 glp’ drugs, and are prescribed to treat type 2 diabetes and obesity.
- Wegovy weight loss: Reduces appetite and can cause rapid weight loss in the short term.
- Mounjaro weight loss: Mimics GLP-1 and GIP hormones to suppress appetite and control glucose temporarily.
- Exenatide extended release: Another example of a GLP-1 drug, available in extended release formulations, used to treat type 2 diabetes and support weight loss.
Some GLP-1 drugs come in extended-release forms, providing longer-lasting effects and more convenient dosing.
GLP-1 drugs help the pancreas produce enough insulin after meals, and higher doses can stimulate the body to produce more insulin, which helps lower blood sugar and support weight loss. Their effectiveness in lowering A1C and supporting weight loss has been demonstrated in clinical studies.
While effective at first, they do not address underlying metabolic issues like gut microbiome imbalances, leptin resistance, or the body’s weight set point.
Common Side Effects of GLP-1 Weight Loss Drugs
While GLP-1 medicines like Wegovy and Mounjaro are effective for weight loss, they can cause side effects for some people. The most common side effects include:
- Nausea or vomiting
- Diarrhea or constipation
- Abdominal pain or bloating
- Headache or fatigue
These symptoms are usually mild to moderate and often decrease over time, but they can affect adherence to the medication. Other side effects, including less common but potentially serious reactions, may also occur. It is important to recognize symptoms that may require prompt attention, such as severe abdominal pain, allergic reactions, or significant mood changes. Some patients may experience emotional changes, such as depression, as a side effect of GLP-1 drugs. If you experience severe or persistent side effects, seek medical attention immediately.
GLP-1 medicines are often administered as injections into fatty tissue, such as the belly, thighs, upper arms, or upper buttocks, with the upper buttocks being a common injection site. Is Wegovy safe for weight loss? Generally, these medicines have a favorable safety profile when used under medical supervision, but always consult your healthcare provider before starting any GLP-1 drug.
How Gut Microbes Influence Obesity and Weight Regain
Your gut is an ultra-high-efficiency energy factory. The gut microbes of obese people and lean people are different from the very start. There are 100 trillion microorganisms living in our gut.
In people with obesity, ‘obesity bacteria’ (Firmicutes) dominate overwhelmingly. These microbes are unbelievably frugal; they extract energy even from food waste that others would simply excrete, and store it as fat.
Even if you reduce your food intake with medication, it doesn’t matter. This microbial factory absorbs incoming food with 200% or 300% efficiency. On top of that, they break through the gut barrier and release toxins (LPS), triggering systemic inflammation.
In 2024, the academic field (J Clin Endocrinol Metab) confirmed: Gut microbes regulate not only your insulin but even your nervous system. Unless you change the microbial ecosystem, your body remains in the same state as a factory that gains weight even by drinking water.
The Fuel Gauge Is Broken: Leptin Resistance
Fat cells send a signal called ‘leptin’ to the brain. It is a notification saying, ‘We have enough fat, so stop eating.’
Common sense suggests that overweight individuals, having more fat, should have stronger leptin signals. But the brains of people with obesity cannot hear this signal at all. This is called leptin resistance.
It is like a fuel tank completely full, yet the dashboard still points to ‘E (Empty).’ The brain mistakenly believes, ‘I am still starving,’ and aggressively drives appetite while slowing down metabolism. Obesity medications chemically trick the brain and temporarily shut the mouth, but they do not repair the broken fuel-gauge sensor.
The Body Remembers Its Past Weight: Set Point Theory
The body has a powerful homeostatic mechanism called the body weight set point.
When obesity persists for a long time, the brain comes to recognize the overweight state as ‘normal.’ Suppose you lose 15 kg using medication. The moment you stop the drug, the body declares a state of emergency:
My fat has been stolen! Bring it back!
It lowers metabolic rate and floods the body with hunger hormones. The reason 67% of people experience rebound weight gain after stopping the medication is that the body is desperately trying to return to its original set point.
Correcting the Misunderstanding: Obesity Is Not a Battle of Willpower
“Can’t you just eat less and endure it?”
If it were that simple, the clinical trial participants who maintained their diets after stopping the medication wouldn’t have regained weight.
Obesity is not the result of laziness. It is a complex, multifactorial chronic disease entangled with genetics, microbes, hormones, and brain science. If a water pipe bursts and floods the house, scooping water with a bucket does nothing. You must fix the broken pipe.
GLP-1 Drugs Are Just a Tool: The Real Answer Is System Redesign
GLP-1 drugs are excellent “pause buttons.” But the moment you press play again, the movie resumes.
Real weight loss is not about suppressing appetite; it is about redesigning the damaged metabolic system.
- Restoring the gut ecosystem: Beyond simple probiotics, you must reduce gut inflammation and weaken the dominance of fat-promoting bacteria. Functional medicine is increasingly focusing on hydrogen inhalation therapy, which provides powerful antioxidant effects that help improve the inflammatory environment of the gut.
- Re-igniting the metabolic engine: Weight loss is not about starving. Techniques like PBM (photobiomodulation) and hyperbaric oxygen therapy (HBOT) are needed to awaken fading mitochondria so the energy you consume is burned as vitality instead of stored as fat.
- Resetting the set point: Your body needs time to improve hormonal resistance so it can accept a new weight as the “normal” one.
Stopping Treatment: What Happens When You Go Off GLP-1 Drugs
If you’re thinking about stopping GLP-1 drug treatment, it’s important to know what to expect. Many people experience weight gain after discontinuing these medications, which can be discouraging. To reduce this risk, work closely with your healthcare provider to create a plan for coming off the medication. This might include gradually lowering your dose, making lifestyle changes, and keeping a close eye on your weight and overall health.
Continuing healthy habits like balanced eating and regular exercise can help you maintain your weight loss and support your long-term health. In some cases, your healthcare provider may suggest alternative treatments or additional support to help you manage your weight after stopping GLP-1 drugs. The key is to stay proactive and committed to your health journey, even after the medication ends.
Conclusion: Choose Sustainable Weight Loss Over Temporary Fixes
Will you depend on medication and chemicals for life? Or will you rebuild your body’s systems so it naturally becomes lean on its own?
The choice is yours. But remember: weight loss borrowed like a loan without paying the interest always returns as an even bigger debt (rebound).
If you want long-term, sustainable weight loss, don’t rely solely on GLP-1 drugs like Wegovy or Mounjaro. Focus on restoring your gut, reactivating your metabolism, and resetting your body’s weight set point. Start your metabolic system redesign today to achieve lasting results.
Ready to achieve real, sustainable weight loss beyond GLP-1 drugs like Wegovy or Mounjaro?
Learn how to restore your gut, reset your set point, and rebuild your metabolic system naturally.
[Explore the BAHI Longevity Program →]
References
- Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab. 2022.
- Berg DA, et al. Discontinuing GLP-1 receptor agonists: A systematic review and meta-analysis. Obesity Reviews. 2025.
- Pillai SS, et al. Exploring the Gut Microbiota: Key Insights Into Its Role in Obesity. J Clin Endocrinol Metab. 2024.
- Flier JS. Leptin physiology and pathophysiology: 30 years after discovery. J Clin Invest. 2024.
